CL2017000867A1 - Composiciones de ácidos grasos y éster de ácido graso autoformadores de micelas y su uso en el tratamiento de patologías - Google Patents
Composiciones de ácidos grasos y éster de ácido graso autoformadores de micelas y su uso en el tratamiento de patologíasInfo
- Publication number
- CL2017000867A1 CL2017000867A1 CL2017000867A CL2017000867A CL2017000867A1 CL 2017000867 A1 CL2017000867 A1 CL 2017000867A1 CL 2017000867 A CL2017000867 A CL 2017000867A CL 2017000867 A CL2017000867 A CL 2017000867A CL 2017000867 A1 CL2017000867 A1 CL 2017000867A1
- Authority
- CL
- Chile
- Prior art keywords
- compositions
- disease
- ester
- fatty acid
- omega
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 7
- 239000000693 micelle Substances 0.000 title abstract 2
- 235000014113 dietary fatty acids Nutrition 0.000 title 2
- 229930195729 fatty acid Natural products 0.000 title 2
- 239000000194 fatty acid Substances 0.000 title 2
- -1 fatty acid ester Chemical class 0.000 title 1
- 150000004665 fatty acids Chemical group 0.000 title 1
- 230000007170 pathology Effects 0.000 title 1
- 235000019197 fats Nutrition 0.000 abstract 3
- 101000694320 Drosophila melanogaster RuvB-like helicase 2 Proteins 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 150000002148 esters Chemical class 0.000 abstract 2
- 201000006417 multiple sclerosis Diseases 0.000 abstract 2
- 229940012843 omega-3 fatty acid Drugs 0.000 abstract 2
- 235000020660 omega-3 fatty acid Nutrition 0.000 abstract 2
- 208000011580 syndromic disease Diseases 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 abstract 1
- 239000012736 aqueous medium Substances 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 206010015037 epilepsy Diseases 0.000 abstract 1
- 230000009246 food effect Effects 0.000 abstract 1
- 235000021588 free fatty acids Nutrition 0.000 abstract 1
- 235000013376 functional food Nutrition 0.000 abstract 1
- 201000010901 lateral sclerosis Diseases 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 abstract 1
- 208000002780 macular degeneration Diseases 0.000 abstract 1
- 208000005264 motor neuron disease Diseases 0.000 abstract 1
- 230000004770 neurodegeneration Effects 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
- 208000033808 peripheral neuropathy Diseases 0.000 abstract 1
- 150000003626 triacylglycerols Chemical class 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/32—Manganese; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Dispersion Chemistry (AREA)
- Emergency Medicine (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462062638P | 2014-10-10 | 2014-10-10 | |
| US201462062652P | 2014-10-10 | 2014-10-10 | |
| US201462062646P | 2014-10-10 | 2014-10-10 | |
| US201462062651P | 2014-10-10 | 2014-10-10 | |
| US201462062643P | 2014-10-10 | 2014-10-10 | |
| US201462062634P | 2014-10-10 | 2014-10-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2017000867A1 true CL2017000867A1 (es) | 2017-11-03 |
Family
ID=54347886
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2017000867A CL2017000867A1 (es) | 2014-10-10 | 2017-04-10 | Composiciones de ácidos grasos y éster de ácido graso autoformadores de micelas y su uso en el tratamiento de patologías |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP3212236A1 (fr) |
| BR (1) | BR112017007428A2 (fr) |
| CA (1) | CA2963952C (fr) |
| CL (1) | CL2017000867A1 (fr) |
| MA (1) | MA40846A (fr) |
| MX (2) | MX2017004324A (fr) |
| WO (1) | WO2016057915A1 (fr) |
| ZA (1) | ZA201702385B (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017193563A1 (fr) * | 2015-11-13 | 2017-11-16 | 深圳君圣泰生物技术有限公司 | Composition, et application et préparation pharmaceutique de cette dernière |
| CN106692973A (zh) * | 2015-11-13 | 2017-05-24 | 深圳君圣泰生物技术有限公司 | 一种组合物及其用途、药物制剂 |
| WO2018027278A1 (fr) | 2016-08-12 | 2018-02-15 | Pharmako Biotechnologies Pty Limited | Compositions d'oméga-3 et méthodes associées |
| EP3579829B1 (fr) * | 2017-02-07 | 2026-03-25 | Fresenius Kabi Deutschland GmbH | Efficacité à long terme du traitement d'une maladie du foie par epa et dha |
| FR3092968B1 (fr) * | 2019-02-22 | 2021-05-21 | Microphyt | Complement alimentaire |
| IT201900007202A1 (it) * | 2019-05-24 | 2020-11-24 | Pavia Farm S R L | Composizione a base di vitamine liposolubili ad elevato assorbimento enterico |
| MX2022001238A (es) | 2019-08-13 | 2022-07-13 | Team Foods Colombia Sa | Composicion lipidica que comprende antioxidantes y polifenoles naturales como alternativa no farmacologica para el tratamiento y la prevencion de nafld. |
| CN115737555B (zh) * | 2022-05-20 | 2024-06-21 | 深圳海王医药科技研究院有限公司 | 一种千金藤素自微乳组合物、制剂及其制备方法 |
| CN117730823A (zh) * | 2022-09-20 | 2024-03-22 | 上海中医药大学 | 原发性硬化性胆管炎合并炎症性肠病的造模方法 |
| WO2026030644A1 (fr) * | 2024-07-31 | 2026-02-05 | Caper Labs, Inc. | Thérapie à l'acide arachidonique pour le traitement de la neutropénie |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2433630A4 (fr) * | 2009-05-22 | 2014-01-08 | Mochida Pharm Co Ltd | Composition auto-émulsifiante d'acide gras 3 |
| AR082930A1 (es) * | 2010-09-08 | 2013-01-16 | Pronova Biopharma Norge As | Composiciones que comprenden una mezcla oleosa de acidos grasos, un tensioactivo y una estatina |
| WO2013093630A2 (fr) * | 2011-12-22 | 2013-06-27 | Pronova Biopharma Norge As | Capsules à libération retardée de gélatine/alginate comprenant des acides gras oméga-3, et leurs procédés et leurs utilisations |
| IN2014DN08449A (fr) * | 2012-03-30 | 2015-05-08 | Sancilio & Company Inc |
-
2015
- 2015-10-08 MA MA040846A patent/MA40846A/fr unknown
- 2015-10-09 CA CA2963952A patent/CA2963952C/fr active Active
- 2015-10-09 EP EP15784877.1A patent/EP3212236A1/fr not_active Withdrawn
- 2015-10-09 BR BR112017007428A patent/BR112017007428A2/pt not_active Application Discontinuation
- 2015-10-09 WO PCT/US2015/054933 patent/WO2016057915A1/fr not_active Ceased
- 2015-10-09 MX MX2017004324A patent/MX2017004324A/es unknown
-
2017
- 2017-04-03 MX MX2020002238A patent/MX2020002238A/es unknown
- 2017-04-04 ZA ZA2017/02385A patent/ZA201702385B/en unknown
- 2017-04-10 CL CL2017000867A patent/CL2017000867A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3212236A1 (fr) | 2017-09-06 |
| MX2017004324A (es) | 2017-07-04 |
| MA40846A (fr) | 2017-09-05 |
| WO2016057915A1 (fr) | 2016-04-14 |
| BR112017007428A2 (pt) | 2017-12-19 |
| MX2020002238A (es) | 2020-07-13 |
| ZA201702385B (en) | 2020-12-23 |
| CA2963952A1 (fr) | 2016-04-14 |
| CA2963952C (fr) | 2023-10-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2017000867A1 (es) | Composiciones de ácidos grasos y éster de ácido graso autoformadores de micelas y su uso en el tratamiento de patologías | |
| CO7121328A2 (es) | Composiciones de ester de ácido graso omega -3 | |
| CL2019001447A1 (es) | Preparación de complejos sólidos de ciclodextrina para suministro de ingredientes farmacéuticos activos oftálmicos. | |
| CY1123942T1 (el) | Συνθεσεις ωμεγα-3 λιπαρων οξεων για τη θεραπεια ασθενειων που επιφερουν βλαβη στο νευρικο συστημα | |
| PH12018500090A1 (en) | Nutritional compositions and methods for promoting cognitive development | |
| AR105190A1 (es) | Composiciones nutricionales y métodos para promover el desarrollo cognitivo | |
| HK1202415A1 (en) | Pharmaceutical compositions comprising dgla, 15-ohepa, and/or 15-hetre and methods of use thereof | |
| PH12017500467A1 (en) | Nutritional compositions comprising sn-1(3) monoacylglycerols for use in the treatment of malabsorption or maldigestion in infants or children | |
| AR105237A1 (es) | Método y composiciones nutricionales que contienen fosfatidiletanolamina, esfingomielina y ácido docosahexaenoico | |
| PH12014500859A1 (en) | Pharmaceutical compositions comprising dgla and/or 15-hetre and methods of use thereof | |
| CL2018003537A1 (es) | Lípidos con un número impar de átomos de carbono y su uso como una composición farmacéutica o como un suplemento nutricional. | |
| MX2021002902A (es) | Composicion farmaceutica para prevenir o tratar la enfermedad del higado graso no alcoholico, que contiene ligando gpr119 como principio activo. | |
| CL2019000766A1 (es) | Composiciones de éster de colina de ácido lipoico y métodos para estabilizar en productos farmacológicos farmacéuticamente relevantes. | |
| HK1244218A1 (zh) | 包括多不饱和游离脂肪酸的毫米胶囊配制品 | |
| AR100028A1 (es) | Composiciones nutricionales que contienen ácido estearidónico | |
| ES2527366B1 (es) | Composición detergente que comprende un biosurfactante de origen vegetal | |
| CL2015001104A1 (es) | Composición de la alimentación para peces | |
| BR112018071142A2 (pt) | métodos de fabricação de formulações nutricionais | |
| BR112018070194A2 (pt) | composto e composição para uso | |
| ECSP15011105A (es) | siRNA Y SU USO EN LOS MÉTODOS Y COMPOSICIONES PARA EL TRATAMIENTO Y/O PREVENCIÓN DE TRASTORNOS OCULARES | |
| AR097148A1 (es) | Composición alimenticia para rumiantes y método para prepararla | |
| WO2015123480A3 (fr) | Compositions et méthodes pour prévenir et/ou traiter une schistosomiase | |
| TH128490A (th) | องค์ประกอบสำหรับทำความสะอาดผิวที่มีโพลิกลีเซอรอลเอสเตอร์และโพลิเมอร์ที่ดัดแปรให้มีสภาพไม่ชอบน้ำ | |
| HK1197736A (en) | Pharmaceutical compositions comprising dgla and/or 15-hetre and methods of use thereof | |
| CR20140350A (es) | Composiciones enriquecidas con dpa de ácidos grasos omega 3 poliinsaturados en forma de ácido libre |